H-Robotics , a rehabilitation robot specialist, announced on the 24th that it had been selected as the main organization for the Ministry of Trade, Industry and Energy's 2025 2nd Bio-industry Technology Development Project in the digital healthcare sector.
The project is called 'Development of an integrated rehabilitation platform based on artificial intelligence and multimodal interaction for customized training for upper limb dysfunction', and the total research period is approximately 4 years and 9 months. The total research cost is 6.3 billion won, of which 5.2 billion won is supported by government subsidies.
Through this project, H-Robotics aims to commercialize an integrated rehabilitation system for upper limb dysfunction caused by neurological paralysis or amputation. The Sungkyunkwan University Industry-Academic Cooperation Foundation, Korea Institute of Industrial Technology, Korea Institute of Machinery and Materials, Sejong University Industry-Academic Cooperation Foundation, and Samsung Seoul Hospital will participate as joint research institutions to establish a professional collaboration system.
Upper limb dysfunction is caused by various neurological causes such as stroke and spinal cord injury, and is one of the main factors leading to a decline in the patient's ability to perform daily life. Current rehabilitation treatment has several challenges such as fatigue due to repetitive tasks of therapists, difficulty in quantitatively measuring treatment effects, and limitations of patient-tailored rehabilitation.
In this study, a hand rehabilitation robot and an integrated robot capable of linking with a prosthetic hand, electromyography-based motion intention detection technology, an AI-based customized rehabilitation system, and immersive content using virtual reality will be developed. Through this, it is expected that rehabilitation training optimized for the condition of each patient will be provided.
H-Robotics expects that through this project, it will be able to support the functional recovery and return to daily life of rehabilitation patients in the future, and also contribute to the training of related professionals and the creation of an industrial ecosystem.
“We plan to secure competitiveness in the global rehabilitation robot market by commercializing patient-tailored treatment technology,” said Dongmin Choi, Chief Technology Officer (CTO) of H-Robotics. “We aim to prove the objective effectiveness of the technology through future clinical trials and medical device licensing.”
- See more related articles
You must be logged in to post a comment.